Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Enea - Market overreaction overshadows the outlook

Enea

Redeye believes investors overreacted to Enea’s Q1 2025 report, sending the stock down ~19% due to a disappointing adjusted EBITDA margin despite solid 6% organic growth. Despite competition concerns and perceived uncertainty, management reiterated growth for the full year, underpinned by recurring revenues and strong order intake. Moreover, it guided flat OPEX for the year. Not much growth is needed at 7.5x EV/FCF for next year, bolstered with an attractive buyback policy. Redeye revised its estimates and fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Enea - Market overreaction overshadows the outlook

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.